Table 4 Predictors of antithrombotic undertreatment among AF patients attending GUH, 2017 (N = 159)
Variables | Â | COR (95% CI) | p-value | AOR (95% CI) | p-value |
|---|---|---|---|---|---|
Clinical type | Valvular AF | 0.329 (0.156–0.698) | 0.004 | 1.116 (0.285–4.367) | 0.875 |
Age | in years | 1.030 (1.011–1.048) | 0.001 | 1.009 (0.979–1.040) | 0.575 |
Hypertension | Yes | 2.187 (1.049–4.562) | 0.037 | 2.849 (0.926–8.770) | 0.068 |
History of stroke/TIA | Yes | 0.194 (0.083–0.453) | 0.000 | 0.054 (0.017–0.175) | 0.000 |
Serum creatinine | mg/dL | 3.328 (1.135–9.753) | 0.028 | 1.901 (0.582–6.208) | 0.287 |
Cardiomegaly | Yes | 0.518 (0.253–1.060) | 0.072 | 0.657 (0.239–1.807) | 0.416 |
Increased LV wall thickness | Yes | 0.127 (0.014–1.170) | 0.069 | 0.135 (0.003–5.344) | 0.286 |
ECG documentation | Yes | 0.507 (0.230–1.121) | 0.093 | 0.351 (0.120–1.029) | 0.056 |
VHD | Yes | 0.377 (0.188–0.757) | 0.006 | 0.392 (0.149–1.036) | 0.059 |
Atenolol | Yes | 0.365 (0.185–0.718) | 0.004 | 0.362 (0.144–0.910) | 0.031 |
Enalapril | Yes | 0.494 (0.227–1.077) | 0.076 | 0.317 (0.107–0.942) | 0.039 |
Monthly benzathine penicillin | Yes | 0.090 (0.025–0.330) | 0.000 | 0.186 (0.030–1.167) | 0.073 |